Oxford says AstraZeneca trials in U.S., Chile, Peru shows COVID vaccine safe

[March 22, 2021]  LONDON (Reuters) - Phase three trials involving more than 32,000 volunteers across all age groups, conducted in the U.S., Chile and Peru have shown that COVID-19 AstraZeneca vaccine is safe and highly effective, the University of Oxford said on Monday.

"These results are great news as they show the remarkable efficacy of the vaccine in a new population and are consistent with the results from Oxford-led trials," Andrew Pollard, who runs the Oxford Vaccine Group, said.

(Reporting by Michael Holden; editing by Guy Faulconbridge)

[© 2021 Thomson Reuters. All rights reserved.]

Copyright 2021 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content